Observational Study of LUMRYZ in Narcolepsy
- First Posted Date
- 2025-01-27
- Last Posted Date
- 2025-03-06
- Lead Sponsor
- Avadel
- Target Recruit Count
- 75
- Registration Number
- NCT06792708
- Locations
- ๐บ๐ธ
Jeremy D McConnell, MD PA, Bradenton, Florida, United States
๐บ๐ธComprehensive Sleep Center, East Lansing, Michigan, United States
๐บ๐ธPatient First MD, Middletown, New Jersey, United States
Safety and Efficacy of FT218 in Idiopathic Hypersomnia (REVITALYZ)
- First Posted Date
- 2024-07-29
- Last Posted Date
- 2025-03-20
- Lead Sponsor
- Avadel
- Target Recruit Count
- 150
- Registration Number
- NCT06525077
- Locations
- ๐บ๐ธ
Alpine Clinical Research Center, Boulder, Colorado, United States
๐บ๐ธFlorida Pediatric Institute, Winter Park, Florida, United States
๐บ๐ธClinical Research Institute, Stockbridge, Georgia, United States
An Open Label Study of FT218 in Subjects With Narcolepsy
- Conditions
- Excessive Daytime SomnolenceSleep DisturbanceSleep Wake DisordersCataplexySleep DisorderNarcolepsy
- Interventions
- First Posted Date
- 2020-06-30
- Last Posted Date
- 2024-01-30
- Lead Sponsor
- Avadel
- Target Recruit Count
- 184
- Registration Number
- NCT04451668
- Locations
- ๐บ๐ธ
Stanford Sleep Medicine, Redwood City, California, United States
๐บ๐ธFL Pediatric Research Institute, Winter Park, Florida, United States
๐บ๐ธOhio Sleep Medicine Institute, Dublin, Ohio, United States
Once-Nightly Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy
- Conditions
- NarcolepsyExcessive Daytime SleepinessCataplexy
- Interventions
- Drug: Placebo
- First Posted Date
- 2016-03-28
- Last Posted Date
- 2022-03-22
- Lead Sponsor
- Avadel
- Target Recruit Count
- 212
- Registration Number
- NCT02720744
- Locations
- ๐จ๐ฆ
Okanagan Clinical Trials Ltd, Kelowna, British Columbia, Canada
๐บ๐ธStanford Sleep Medicine, Redwood City, California, United States
๐บ๐ธFL Pediatric REsearch Institute, Winter Park, Florida, United States